APOB and Insulin resistance: Dyslipidemia in patients with MetS may be caused by a combination of increased catabolism of HDL-apo A-I particles, overproduction of very LDL apo B, and decreased catabolism of apo B containing particles: these abnormalities may be consequences of insulin resistance [32].